Ewa Ehrenborg (E Ehrenborg)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 2

Top Topics

Endoplasmic Reticulum Stress

Low Density Lipoprotein

Chronic Myeloid Leukemia

Top Venues

Journal of internal medicine

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Miguel Carracedo, Sven-Christian Pawelzik, Gonzalo Artiach, Marianne G Pouwer, Oscar Plunde, Peter Saliba-Gustafsson, Ewa Ehrenborg, Per Eriksson, Elsbet Pieterman, Leif Stenke, Hans M G Princen, Anders Franco-Cereceda, Magnus Bäck
The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis. British journal of pharmacology 179 (19) (2022)
Peter Saliba-Gustafsson, Matteo Pedrelli, K Gertow, O Werngren, V Janas, S Pourteymour, D Baldassarre, E Tremoli, F Veglia, R Rauramaa, A J Smit, P Giral, Sudhir Kurl, M Pirro, U de Faire, S E Humphries, A Hamsten, null null, I Gonçalves, M Orho-Melander, A Franco-Cereceda, Jan Borén, Per Eriksson, J Magné, Paolo Parini, Ewa Ehrenborg
Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed-forward loop between LXR and autophagy. Journal of internal medicine 286 (6) (2019)